These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21791993)

  • 1. New device simplifies workstation preparation for malignant hyperthermia-susceptible patients.
    Feldman JM
    Anesthesiology; 2011 Aug; 115(2):434; author reply 436-7. PubMed ID: 21791993
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: when are they really clean?
    Wappler F
    Anesthesiology; 2011 Aug; 115(2):434-5; author reply 436-7. PubMed ID: 21791992
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.
    Kim TW; Nemergut ME
    Anesthesiology; 2011 Jan; 114(1):205-12. PubMed ID: 21169802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anesthesia for patients with a history of malignant hyperthermia.
    Wappler F
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):417-22. PubMed ID: 20173632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of the Dräger Fabius GS workstation for malignant hyperthermia-susceptible patients.
    Whitty RJ; Wong GK; Petroz GC; Pehora C; Crawford MW
    Can J Anaesth; 2009 Jul; 56(7):497-501. PubMed ID: 19399571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia].
    Jantzen JP; Eck J; Kleemann PP
    Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child.
    Allison KR
    Paediatr Anaesth; 2007 Jan; 17(1):1-6. PubMed ID: 17184424
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anesthesia risks].
    Ramé A; Mouzat L
    Rev Infirm; 2007; (127):21-4. PubMed ID: 17375756
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
    Gunter JB; Ball J; Than-Win S
    Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing anesthesia equipment for suspected malignant hyperthermia episodes.
    Wald A
    J Clin Eng; 1982; 7(4):335-8. PubMed ID: 10258775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More on anesthesia machines and malignant hyperpyrexia.
    Cooper JB; Philip JH
    Anesthesiology; 1989 Mar; 70(3):561-2. PubMed ID: 2923309
    [No Abstract]   [Full Text] [Related]  

  • 12. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group.
    Rüffert H; Bastian B; Bendixen D; Girard T; Heiderich S; Hellblom A; Hopkins PM; Johannsen S; Snoeck MM; Urwyler A; Glahn KPE;
    Br J Anaesth; 2021 Jan; 126(1):120-130. PubMed ID: 33131754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrasonography in anesthesiology--introduction and overview].
    Roewer N
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Nov; 41(11):738-9. PubMed ID: 17151987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant hyperthermia. Immediate treatment and procedure in another anesthesia].
    Schuh FT
    Dtsch Med Wochenschr; 1981 Oct; 106(43):1431-2. PubMed ID: 7285828
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of neuroleptoanesthesia for carrying out a Harrington intervention in a patient probably susceptible to malignant hyperthermia].
    Lauri A; Corbari M; Galli C; Marri M
    Minerva Anestesiol; 1989 Sep; 55(9):331-5. PubMed ID: 2633080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia and the otolaryngologist.
    Chang CY; Scher RL
    Ear Nose Throat J; 2003 Jun; 82(6):433-6. PubMed ID: 12861868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General anesthesia in a malignant hyperthermia susceptible patient.
    Jones JE; Dierdorf SF; Clapp DW
    J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
    [No Abstract]   [Full Text] [Related]  

  • 20. Propofol anesthesia in the malignant hyperthermia susceptible patient.
    Klotz RW
    Nurse Anesth; 1991 Mar; 2(1):33-5. PubMed ID: 2021658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.